ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,716Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 63

$757K Total Retail Price of All Prescriptions

Rank: 3 out of 63

439 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
35% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 439 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

5% of this provider’s 439 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

0% of this provider’s 9,228 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$71 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
AMLODIPINE BESYLATE 431 381 1 3
PRAVASTATIN SODIUM 340 314 2 16
LISINOPRIL 337 288 3 2
LEVOTHYROXINE SODIUM 269 233 4 1
OMEPRAZOLE 256 231 5 6
SIMVASTATIN 225 192 6 5
FUROSEMIDE 224 205 7 4
TRAMADOL HCL 211 203 8 12
HYDROCHLOROTHIAZIDE 190 170 9 15
METOPROLOL SUCCINATE 189 169 10 13
DONEPEZIL HCL 163 155 11 14
ATORVASTATIN CALCIUM 157 149 12 10
METOPROLOL TARTRATE 152 144 13 7
DIOVAN 148 147 14 41
JANTOVEN 147 147 15 28
PANTOPRAZOLE SODIUM 139 132 16 23
MIRTAZAPINE 139 139 16 8
GABAPENTIN 139 101 16 21
WARFARIN SODIUM 132 120 19 9
METFORMIN HCL 131 88 20 17
RANITIDINE HCL 124 101 21 27
TRAZODONE HCL 113 103 22 18
CITALOPRAM HBR 107 101 23 11
CYMBALTA 106 72 24 43
LOSARTAN POTASSIUM 99 92 25 20
NAMENDA 98 98 26 24
ATENOLOL 84 73 27 22
NEXIUM 84 71 27 72
ESCITALOPRAM OXALATE 84 79 27 32
CARVEDILOL 84 73 27 39
CLOPIDOGREL 79 75 31 37
METFORMIN HCL ER 77 56 32 73
CIPROFLOXACIN HCL 76 71 33 68
LOVASTATIN 76 49 33 25
HYDROCODONE-ACETAMINOPHEN 71 49 S3 35 36
LIDODERM 68 67 36 65
LACTULOSE 67 55 37 47
ZOLPIDEM TARTRATE 65 49 38 40
ADVAIR DISKUS 64 57 39 42
ZETIA 62 49 40 140
CRESTOR 61 50 41 76
MELOXICAM 61 45 41 91
HYDRALAZINE HCL 60 54 43 58
ALLOPURINOL 59 55 44 55
AZITHROMYCIN 58 47 45 59
LANTUS 56 44 46 29
FAMOTIDINE 53 39 47 106
ALENDRONATE SODIUM 53 53 47 46
AMIODARONE HCL 52 42 49 157
RISPERIDONE 51 45 50 33
LISINOPRIL-HYDROCHLOROTHIAZIDE 50 33 51 107
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 6, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.